The approval of medicines called second-generation antipsychotics has allowed bipolar I and some conditions that come with it to be treated. A person who has bipolar I disorder can go through various ...

Milsaperidone is an active metabolite of iloperidone ...

(Mass Appeal) – March 30th marks World Bipolar Day, a day created to encourage awareness and increase education surrounding this complex condition with hopes of eliminating the social stigma ...

The FDA OKs pill schizophrenia and bipolar disorder treatment with Bysanti, a new atypical antipsychotic approved for adults.

The approval of medicines called second-generation antipsychotics has allowed bipolar I and other associated conditions to be treated. A person with bipolar I disorder can go through various mood ...

The major differences between bipolar I and bipolar II disorder were highlighted in a presentation at the 2022 Neuroscience Education Institute (NEI) Congress. The aim of the presentation was to ...

Abilify Asimtufii, the bipolar I disorder treatment from Otsuka and Lundbeck, has entered the world of CGI animation as part of a multichannel direct-to-consumer (DTC) campaign. The two drugmakers ...

Milsaperidone, a new chemical entity, is the major active metabolite of iloperidone (Fanapt) and had been demonstrated to be bioequivalent to iloperidone.

Nearly 5 million Americans navigate the complex challenges of bipolar I disorder daily, facing dramatic shifts between manic highs and depressive lows that can derail careers, relationships and ...

For many people who have bipolar I, lithium is that most elusive of pharmacological treatments, the “magic bullet”—a single intervention that completely eliminates the symptoms of a disease. Since the ...